These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 23501043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
    Lim DW, Levesque CL, Vine DF, Muto M, Koepke JR, Nation PN, Wizzard PR, Li J, Bigam DL, Brubaker PL, Turner JM, Wales PW.
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr 01; 312(4):G390-G404. PubMed ID: 28104586
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P.
    Clin Nutr; 2013 Oct 01; 32(5):713-21. PubMed ID: 23587733
    [Abstract] [Full Text] [Related]

  • 9. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B.
    Gastroenterology; 2012 Dec 01; 143(6):1473-1481.e3. PubMed ID: 22982184
    [Abstract] [Full Text] [Related]

  • 10. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.
    Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB.
    Gastroenterology; 2001 Mar 01; 120(4):806-15. PubMed ID: 11231933
    [Abstract] [Full Text] [Related]

  • 11. Role of glucagon-like peptide-2 deficiency in neonatal short-bowel syndrome using neonatal piglets.
    Hua Z, Turner JM, Sigalet DL, Wizzard PR, Nation PN, Mager DR, Ball RO, Pencharz PB, Wales PW.
    Pediatr Res; 2013 Jun 01; 73(6):742-9. PubMed ID: 23481550
    [Abstract] [Full Text] [Related]

  • 12. Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate.
    Holst JJ, Hartmann B, Gottschalck IB, Jeppesen PB, Miholic J, Henriksen DB.
    Scand J Gastroenterol; 2007 Jul 01; 42(7):814-20. PubMed ID: 17558904
    [Abstract] [Full Text] [Related]

  • 13. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.
    Jeppesen PB, Hartmann B, Thulesen J, Hansen BS, Holst JJ, Poulsen SS, Mortensen PB.
    Gut; 2000 Sep 01; 47(3):370-6. PubMed ID: 10940274
    [Abstract] [Full Text] [Related]

  • 14. GLP-2 and mesenteric blood flow.
    Hansen LB.
    Dan Med J; 2013 May 01; 60(5):B4634. PubMed ID: 23673268
    [Abstract] [Full Text] [Related]

  • 15. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
    Vegge A, Thymann T, Lund P, Stoll B, Bering SB, Hartmann B, Jelsing J, Qvist N, Burrin DG, Jeppesen PB, Holst JJ, Sangild PT.
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug 15; 305(4):G277-85. PubMed ID: 23764891
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
    Sueyoshi R, Woods Ignatoski KM, Okawada M, Hartmann B, Holst J, Teitelbaum DH.
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug 15; 307(4):G410-9. PubMed ID: 24970775
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome.
    Kunkel D, Basseri B, Low K, Lezcano S, Soffer EE, Conklin JL, Mathur R, Pimentel M.
    Neurogastroenterol Motil; 2011 Aug 15; 23(8):739-e328. PubMed ID: 21557790
    [Abstract] [Full Text] [Related]

  • 18. Exogenous glucagon-like peptide-2 improves outcomes of intestinal adaptation in a distal-intestinal resection neonatal piglet model of short bowel syndrome.
    Suri M, Turner JM, Sigalet DL, Wizzard PR, Nation PN, Ball RO, Pencharz PB, Brubaker PL, Wales PW.
    Pediatr Res; 2014 Oct 15; 76(4):370-7. PubMed ID: 24995913
    [Abstract] [Full Text] [Related]

  • 19. Modern treatment of short bowel syndrome.
    Jeppesen PB.
    Curr Opin Clin Nutr Metab Care; 2013 Sep 15; 16(5):582-7. PubMed ID: 23924950
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
    Sigalet DL, Bawazir O, Martin GR, Wallace LE, Zaharko G, Miller A, Zubaidi A.
    Dig Dis Sci; 2006 Sep 15; 51(9):1557-66. PubMed ID: 16927140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.